Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med (2009) 2.49

Vitamin D and prostate cancer prognosis: a Mendelian randomization study. World J Urol (2015) 2.01

Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr (2010) 1.73

Vitamin D effects on pregnancy and the placenta. Placenta (2010) 1.53

Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog (2013) 1.39

Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol (2012) 1.35

Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D. PLoS One (2012) 1.28

Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res (2012) 1.24

Back to the future: a new look at 'old' vitamin D. J Endocrinol (2008) 1.20

Vitamin D and respiratory health. Clin Exp Immunol (2009) 1.15

Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D Levels among African Americans. PLoS One (2011) 1.12

Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies. Am J Physiol Endocrinol Metab (2012) 1.09

Vitamin D binding protein is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers. J Bone Miner Res (2013) 1.08

Vitamin D-binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: data from a randomized, controlled trial. J Clin Endocrinol Metab (2014) 1.07

Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer (2012) 1.06

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev (2013) 1.03

Glycosylation status of vitamin D binding protein in cancer patients. Protein Sci (2009) 1.03

The vitamin d receptor and T cell function. Front Immunol (2013) 1.03

Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer (2012) 1.02

Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore. Br J Nutr (2012) 0.97

Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother (2013) 0.97

New vitamin D analogs as potential therapeutics in melanoma. Expert Rev Anticancer Ther (2012) 0.94

Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment. Proteomics Clin Appl (2008) 0.94

Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D₃ or D₂supplementation. Nutr J (2013) 0.93

Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology. Cell Death Differ (2012) 0.93

Vitamin D in a northern Canadian first nation population: dietary intake, serum concentrations and functional gene polymorphisms. PLoS One (2012) 0.92

Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer (2014) 0.92

An insight into the changes in human plasma proteome on adaptation to hypobaric hypoxia. PLoS One (2013) 0.92

Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease. Front Immunol (2015) 0.91

Proteomic changes in rat thyroarytenoid muscle induced by botulinum neurotoxin injection. Proteomics (2008) 0.90

Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev (2011) 0.90

Vitamin D insufficiency in Arabs and South Asians positively associates with polymorphisms in GC and CYP2R1 genes. PLoS One (2014) 0.90

Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma. Int J Cancer (2014) 0.89

Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. PLoS One (2014) 0.89

Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control (2014) 0.87

Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS. J Biomol Tech (2008) 0.86

Physical performance and 25-hydroxyvitamin D: a cross-sectional study of pregnant Swedish and Somali immigrant women and new mothers. BMC Pregnancy Childbirth (2013) 0.85

Insulin resistance indices are inversely associated with vitamin D binding protein concentrations. J Clin Endocrinol Metab (2013) 0.84

Vitamin d binding protein and bone health. Int J Endocrinol (2014) 0.84

The emerging role of vitamin D binding protein in multiple sclerosis. J Neurol (2010) 0.84

Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells. Cancer Prev Res (Phila) (2014) 0.83

Genome-wide association study of circulating vitamin D-binding protein. Am J Clin Nutr (2014) 0.83

Vitamin D binding protein genotype is associated with serum 25-hydroxyvitamin D and PTH concentrations, as well as bone health in children and adolescents in Finland. PLoS One (2014) 0.83

Effect of vitamin D-binding protein genotype on the development of asthma in children. Ann Allergy Asthma Immunol (2014) 0.83

Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis. Pediatr Nephrol (2011) 0.83

Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. J Proteomics (2012) 0.83

Serum vitamin D, vitamin D binding protein, and lung cancer survival. Lung Cancer (2014) 0.82

A GC polymorphism associated with serum 25-hydroxyvitamin D level is a risk factor for hip fracture in Japanese patients with rheumatoid arthritis: 10-year follow-up of the Institute of Rheumatology, Rheumatoid Arthritis cohort study. Arthritis Res Ther (2014) 0.81

Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur J Endocrinol (2016) 0.81

VITAMIN D-BINDING PROTEIN IN HEALTHY PRE- AND POSTMENOPAUSAL WOMEN: RELATIONSHIP WITH ESTRADIOL CONCENTRATIONS. Endocr Pract (2015) 0.80

Vitamin D-binding protein haplotype is associated with hospitalization for RSV bronchiolitis. Clin Exp Allergy (2014) 0.80

Vitamin D Deficiency in Uygurs and Kazaks Is Associated with Polymorphisms in CYP2R1 and DHCR7/NADSYN1 Genes. Med Sci Monit (2015) 0.80

Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study. Cancer Prev Res (Phila) (2016) 0.80

Vitamin D Binding Protein Is Not Involved in Vitamin D Deficiency in Patients with Chronic Kidney Disease. Biomed Res Int (2015) 0.79

Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease. Fluids Barriers CNS (2013) 0.79

Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms. Mol Brain (2013) 0.79

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study. Cancer Causes Control (2014) 0.79

SNP rs11185644 of RXRA gene is identified for dose-response variability to vitamin D3 supplementation: a randomized clinical trial. Sci Rep (2017) 0.78

Association of common gene variants in vitamin D modulating genes and colon cancer recurrence. J Cancer Res Clin Oncol (2013) 0.78

Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia? Breast Cancer Res (2015) 0.78

Alteration in the expression of proteins in unexplained recurrent pregnancy loss compared with in the normal placenta. J Reprod Dev (2014) 0.78

Vitamin D and urological cancers. Cent European J Urol (2016) 0.78

Influence of Vitamin D Binding Protein on Accuracy of 25-Hydroxyvitamin D Measurement Using the ADVIA Centaur Vitamin D Total Assay. Int J Endocrinol (2014) 0.78

Genetic and environmental factors are associated with serum 25-hydroxyvitamin D concentrations in older African Americans. J Nutr (2015) 0.78

Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancer. Sci Rep (2015) 0.78

Relationship between polymorphisms in vitamin D metabolism-related genes and the risk of rickets in Han Chinese children. BMC Med Genet (2013) 0.77

Biomarker discovery in serum from patients with carotid atherosclerosis. Cerebrovasc Dis Extra (2011) 0.77

The relationship between vitamin D status and muscle strength in young healthy adults from sunny climate countries currently living in the northeast of Scotland. Osteoporos Int (2017) 0.77

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer. BMC Cancer (2014) 0.76

Vitamin D-binding protein and pancreatic cancer: a nested case-control study. Am J Clin Nutr (2015) 0.76

Vitamin D status of patients with early inflammatory arthritis. Clin Rheumatol (2014) 0.76

Functional status and inflammation after preseason training program in professional and recreational soccer players: a proteomic approach. J Sports Sci Med (2011) 0.76

Polymorphisms in GC and NADSYN1 Genes are associated with vitamin D status and metabolic profile in Non-diabetic adults. BMC Endocr Disord (2013) 0.76

Vitamin d-binding protein levels in plasma and gingival crevicular fluid of patients with generalized aggressive periodontitis. Int J Endocrinol (2014) 0.76

Investigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a Review. Int J Endocrinol (2016) 0.75

Plasma Actin-free Gc-globulin in Patients with Chronic or Acute-on-chronic Liver Failure Caused by Hepatitis B Virus. Gastroenterology Res (2009) 0.75

Human plasma protein polymorphisms and the persistence of cultural diversity. Proc Natl Acad Sci U S A (2012) 0.75

Vitamin D Receptor Gene Polymorphism and the Risk of Colorectal Cancer: A Nested Case-Control Study. PLoS One (2016) 0.75

Albuminoid genes: evolving at the interface of dispensability and selection. Genome Biol Evol (2014) 0.75

Relationship between vitamin D-binding protein polymorphisms and blood vitamin D level in Korean patients with COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study. PLoS One (2017) 0.75

Placental Vitamin D-Binding Protein Expression in Human Idiopathic Fetal Growth Restriction. J Pregnancy (2017) 0.75

Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk. Int J Mol Sci (2016) 0.75

Haptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis. Arthritis Res Ther (2015) 0.75

Expression-Based Genome-Wide Association Study Links Vitamin D-Binding Protein With Autoantigenicity in Type 1 Diabetes. Diabetes (2016) 0.75

Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis. Am J Gastroenterol (2016) 0.75

Analytical considerations for the biochemical assessment of vitamin D status. Ther Adv Musculoskelet Dis (2017) 0.75

Real-life use of vitamin D3-fortified bread and milk during a winter season: the effects of CYP2R1 and GC genes on 25-hydroxyvitamin D concentrations in Danish families, the VitmaD study. Genes Nutr (2014) 0.75

State- and trait-dependent associations of vitamin-D with brain function during aging. Neurobiol Aging (2015) 0.75

Normalized vitamin D metabolite concentrations are better correlated to pharmacological effects than measured concentrations. Future Sci OA (2015) 0.75

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study. PLoS One (2016) 0.75

The Safety Limits Of An Extended Fast: Lessons from a Non-Model Organism. Sci Rep (2016) 0.75

GC Gene Polymorphisms and Vitamin D-Binding Protein Levels Are Related to the Risk of Generalized Aggressive Periodontitis. Int J Endocrinol (2016) 0.75

Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: a meta-analysis. J Thorac Dis (2015) 0.75

Association of vitamin D binding protein polymorphisms with bronchopulmonary dysplasia: a case-control study of gc globulin and bronchopulmonary dysplasia. J Perinatol (2015) 0.75

Comparative proteomic analysis of plasma proteins in patients with age-related macular degeneration. Int J Ophthalmol (2014) 0.75

L-cysteine supplementation upregulates glutathione (GSH) and vitamin D binding protein (VDBP) in hepatocytes cultured in high glucose and in vivo in liver, and increases blood levels of GSH, VDBP, and 25-hydroxy-vitamin D in Zucker diabetic fatty rats. Mol Nutr Food Res (2016) 0.75

Methylation of the Vitamin D Receptor (VDR) Gene, Together with Genetic Variation, Race, and Environment Influence the Signaling Efficacy of the Toll-Like Receptor 2/1-VDR Pathway. Front Immunol (2017) 0.75

Total and free circulating vitamin D and vitamin D binding protein in relation to colorectal cancer risk in a prospective study of African Americans. Cancer Epidemiol Biomarkers Prev (2017) 0.75

PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science (2004) 3.34

Testing for recombinant human erythropoietin. J Appl Physiol (1985) (2008) 3.02

False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood (2006) 2.06

Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant (2005) 1.72

Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc (2002) 1.68

Development of an affordable dye-stained microalbuminuria screening test. Nephrol Dial Transplant (2008) 1.50

Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease. Clin Chem Lab Med (2015) 1.41

Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J Immunol (2008) 1.38

Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol (2015) 1.33

A transgenic FOXJ1-Cre system for gene inactivation in ciliated epithelial cells. Am J Respir Cell Mol Biol (2007) 1.28

Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta (2008) 1.23

New ionization methods and miniature mass spectrometers for biomedicine: DESI imaging for cancer diagnostics and paper spray ionization for therapeutic drug monitoring. Faraday Discuss (2011) 1.21

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. Am J Respir Crit Care Med (2010) 1.14

Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma. J Immunol (2002) 1.13

Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment. J Biol Chem (2005) 1.10

Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clin Chem (2010) 1.09

Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med (2004) 1.09

Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta (2004) 1.08

Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol (2012) 1.05

Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview. Perit Dial Int (2009) 1.05

Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia. Clin Chem Lab Med (2011) 1.05

Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma. J Thorac Oncol (2011) 1.00

Flow cytometry as a new method to quantify the cellular content of human saliva and its relation to gingivitis. Clin Chim Acta (2002) 0.97

Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res (2008) 0.96

Haptoglobin polymorphism and infection. Adv Clin Chem (2010) 0.95

Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment. Clin Chem Lab Med (2008) 0.94

Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin Chem (2003) 0.94

Quantitative evaluation of urinalysis test strips. Clin Chem (2002) 0.92

Haptoglobin polymorphism in patients with preeclampsia. Clin Chem Lab Med (2006) 0.92

Glycosylation of prostate specific antigen and its potential diagnostic applications. Clin Chim Acta (2012) 0.91

Gas-flow assisted ion transfer for mass spectrometry. J Mass Spectrom (2012) 0.90

The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor. Chest (2011) 0.90

Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate. J Nephrol (2014) 0.89

Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone (2005) 0.89

Non-oxidative ethanol metabolites as a measure of alcohol intake. Clin Chim Acta (2012) 0.89

A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels. PLoS One (2012) 0.89

Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci (2010) 0.88

Glycated nail proteins: a new approach for detecting diabetes in developing countries. Trop Med Int Health (2013) 0.88

Biologically active, magnICON®-expressed EPO-Fc from stably transformed Nicotiana benthamiana plants presenting tetra-antennary N-glycan structures. J Biotechnol (2012) 0.87

Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study. J Thorac Oncol (2011) 0.86

Serum free hemoglobin concentrations in healthy individuals are related to haptoglobin type. Clin Chem (2005) 0.86

Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem (2014) 0.86

Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients. Clin Chem Lab Med (2008) 0.85

Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese. Clin Chim Acta (2005) 0.85

Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy. Kidney Int (2003) 0.85

Detection of explosives as negative ions directly from surfaces using a miniature mass spectrometer. Anal Chem (2010) 0.84

Urinary beta-trace protein as a new renal tubular marker. Clin Chem (2009) 0.84

Evaluation of Sysmex UF-1000i for use in cerebrospinal fluid analysis. Clin Chim Acta (2008) 0.83

Automated flow cytometry analysis of peritoneal dialysis fluid. Nephrol Dial Transplant (2004) 0.83

Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurovasc Res (2010) 0.83

Chemiluminescent image detection of haptoglobin phenotyping after polyacrylamide gel electrophoresis. Anal Chem (2004) 0.82

Creatine supplementation decreases homocysteine in an animal model of uremia. Kidney Int (2003) 0.82

Determination of beta2-agonists by ion chromatography with direct conductivity detection. J Pharm Biomed Anal (2005) 0.81

Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum. Clin Chem (2009) 0.81

Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol Dial Transplant (2007) 0.81

Birth weight in relation to sex steroid status and body composition in young healthy male siblings. J Clin Endocrinol Metab (2010) 0.81

Proteolysis is a confounding factor in the interpretation of faecal calprotectin. Clin Chem Lab Med (2015) 0.81

Value and pitfalls in iodine fortification and supplementation in the 21st century. Br J Nutr (2011) 0.80

Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem (2010) 0.80

Enantiomeric separation of beta-blockers by HPLC using (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid as chiral stationary phase. J Pharm Biomed Anal (2003) 0.80

Java project on periodontal diseases: periodontal bone loss in relation to environmental and systemic conditions. J Clin Periodontol (2015) 0.80

High-throughput screening normalized to biological response: application to antiviral drug discovery. J Biomol Screen (2013) 0.80

Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker. Adv Clin Chem (2013) 0.80

Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis. Clin Biochem (2013) 0.79

Reactive paper spray mass spectrometry for in situ identification of quinones. Rapid Commun Mass Spectrom (2015) 0.79

Decorin-mediated inhibition of cholangiocarcinoma cell growth and migration and promotion of apoptosis are associated with E-cadherin in vitro. Tumour Biol (2013) 0.79

Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. J Clin Immunol (2013) 0.79

Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation. Is time still on our side? Atherosclerosis (2012) 0.79

Compensating for the influence of total serum protein in the Schwartz formula. Clin Chem Lab Med (2012) 0.78

Clinical efficacy maintains patients' positive attitudes toward fecal microbiota transplantation. Medicine (Baltimore) (2016) 0.78

Separation and characterization of sucrose esters from Oriental tobacco leaves using accelerated solvent extraction followed by SPE coupled to HPLC with ion-trap MS detection. J Sep Sci (2013) 0.78

Carbohydrate deficient transferrin in a driver's license regranting program. Alcohol Alcohol (2012) 0.78

Folates from metabolically engineered rice: a long-term study in rats. Mol Nutr Food Res (2015) 0.78

Iron status in black persons is not influenced by haptoglobin polymorphism. Clin Chem Lab Med (2002) 0.78

Chronic nicotine exposure and acute kidney injury: new concepts and experimental evidence. Nephrol Dial Transplant (2013) 0.78

Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients. Kidney Int (2004) 0.78

Use of nanomaterials in capillary and microchip electrophoresis. Expert Rev Proteomics (2007) 0.78

Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander. Am J Nephrol (2016) 0.78

Sex hormone-binding globulin at the crossroad of body composition, somatotropic axis and insulin/glucose homeostasis in young healthy men. Clin Endocrinol (Oxf) (2012) 0.78

Diagnostic performance of combined specific urinary proteins and urinary flow cytometry in urinary tract pathology. Clin Chem Lab Med (2007) 0.77

Creatine supplementation does not affect kidney function in an animal model with pre-existing renal failure. Nephrol Dial Transplant (2003) 0.77

Direct chemiluminescent imaging detection of human serum proteins in two-dimensional polyacrylamide gel electrophoresis. Proteomics (2007) 0.77

Flow-injection with enhanced chemiluminescence detection of ofloxacin in human plasma. Luminescence (2005) 0.77

Association of haptoglobin phenotypes with the development of Kaposi's sarcoma in HIV patients. Arch Dermatol Res (2011) 0.77

Immunochemically unreactive albumin in urine: fiction or reality? Crit Rev Clin Lab Sci (2011) 0.77

Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients. Clin Chem Lab Med (2009) 0.77

The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer. Clin Chem Lab Med (2009) 0.77

Screening of complicated matrixes with paper assisted ultrasonic spray ionization mass spectrometry. J Am Soc Mass Spectrom (2014) 0.77

Alleviation of electrochemical oxidation for peptides and proteins in electrospray ionization: obtaining more accurate mass spectra with induced high voltage. Anal Chem (2015) 0.77

Direct sequencing of a disulfide-linked peptide with electrospray ionization tandem mass spectrometry. Analyst (2015) 0.76

Rapid detection of urushiol allergens of Toxicodendron genus using leaf spray mass spectrometry. Analyst (2012) 0.76

Detection of antibodies in cardiac autoimmunity. Clin Chim Acta (2009) 0.76

Enhanced separation of purine and pyrimidine bases using carboxylic multiwalled carbon nanotubes as additive in capillary zone electrophoresis. Electrophoresis (2006) 0.76

Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption. Clin Lung Cancer (2012) 0.76

Homocysteine and methionine transamination. Am J Kidney Dis (2003) 0.76

Binding States of Protein-Metal Complexes in Cells. Anal Chem (2016) 0.76

Donor haptoglobin phenotype determines outcome following liver transplantation. Transpl Int (2011) 0.76